Updated yearly (last 12 July 2024): https://doi.org/10.1093/cid/ciae403
Differences from ESCMID 2022:
And of course: it’s updated annually!
Listen here: https://idiotspodcasting.buzzsprout.com/1782416/episodes/16764936-104-idsa-difficult-to-treat-gram-negatives-guidance-2024-with-breakpoints-podcast
It’s A Breakpoints Breakout!
| Episodes |
|---|
| https://www.buzzsprout.com/1782416/episodes/10848117 |
| https://www.buzzsprout.com/1782416/episodes/11081673 |
| https://www.buzzsprout.com/1782416/episodes/11082098 |
| https://www.buzzsprout.com/1782416/episodes/12537247 |
| https://www.buzzsprout.com/1782416/episodes/13332392 |
| https://www.buzzsprout.com/1782416/episodes/13332456 |
| https://www.buzzsprout.com/1782416/episodes/13694614 |
| https://www.buzzsprout.com/1782416/episodes/13694887 |
| https://www.buzzsprout.com/1782416/episodes/13831903 |
| Breakpoints mini-series on DTR can be found here: |
| https://breakpoints-sidp.org/gram-negative-resistance/ |
| Breakpoints mini-series on Breakpoint setting can be found here: |
| https://breakpoints-sidp.org/breakpoints-talks-breakpoints/ |
Updated yearly (last 12 July 2024): https://doi.org/10.1093/cid/ciae403
Differences from ESCMID 2022:
And of course: it’s updated annually!
Definition: Ceftriaxone MIC ≥2
Also: avoid oral step-down to:
Questions for Breakpoints: